Massimo Lamanna

Massimo Lamanna is a Key Account Manager specializing in Rare Diseases and Orphan Drugs at Amicus Therapeutics since April 2023, where responsibilities include fostering customer relationships and executing strategic account plans. Previously, Massimo held multiple roles at Roche from April 2015 to April 2023, including Patient Journey Partner and Rare Diseases Specialist, focusing on the launch of monoclonal antibodies for Hemophilia and managing key healthcare professional relationships. Prior experience includes positions at InterMune, Merck, Novartis, and MENARINI Group, emphasizing expertise in orphan diseases, pharmaceutical access, stakeholder engagement, and scientific communication. Massimo Lamanna holds a degree in Scientific Information on Pharmaceuticals from the University of Messina (2003-2007).